GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » EV-to-Revenue

Liaoning Chengda Biotechnology Co (SHSE:688739) EV-to-Revenue : 3.33 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Liaoning Chengda Biotechnology Co's enterprise value is ¥5,872 Mil. Liaoning Chengda Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,761 Mil. Therefore, Liaoning Chengda Biotechnology Co's EV-to-Revenue for today is 3.33.

The historical rank and industry rank for Liaoning Chengda Biotechnology Co's EV-to-Revenue or its related term are showing as below:

SHSE:688739' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.01   Med: 4.89   Max: 13.69
Current: 3.33

During the past 11 years, the highest EV-to-Revenue of Liaoning Chengda Biotechnology Co was 13.69. The lowest was 3.01. And the median was 4.89.

SHSE:688739's EV-to-Revenue is ranked better than
71.03% of 1039 companies
in the Biotechnology industry
Industry Median: 8.18 vs SHSE:688739: 3.33

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Liaoning Chengda Biotechnology Co's stock price is ¥27.65. Liaoning Chengda Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.23. Therefore, Liaoning Chengda Biotechnology Co's PS Ratio for today is 6.53.


Liaoning Chengda Biotechnology Co EV-to-Revenue Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co EV-to-Revenue Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 12.25 3.80 4.52

Liaoning Chengda Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 4.66 4.93 4.52 3.50

Competitive Comparison of Liaoning Chengda Biotechnology Co's EV-to-Revenue

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's EV-to-Revenue falls into.



Liaoning Chengda Biotechnology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Liaoning Chengda Biotechnology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5871.604/1761.289
=3.33

Liaoning Chengda Biotechnology Co's current Enterprise Value is ¥5,872 Mil.
Liaoning Chengda Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,761 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co  (SHSE:688739) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Liaoning Chengda Biotechnology Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=27.65/4.233
=6.53

Liaoning Chengda Biotechnology Co's share price for today is ¥27.65.
Liaoning Chengda Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co (SHSE:688739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co (SHSE:688739) Headlines

No Headlines